No differences were recorded in actuarial patient survival, delayed graft function, biopsy-proven acute rejection rates, and renal function analysis.

• 两组的精确患者存活率、移植物功能恢复延迟、活检证实的急性排斥率以及移植肾功能分析之间没有差别。